HIFU Combined with TACE Treatment of HCC: the Clinical Results

来源 :2013年第一届国际微无创医学长江高峰论坛(2013 The 1st Yangtze International Sum | 被引量 : 0次 | 上传用户:yxhangyong
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Objective To study the efficacy, prognosis and safety of high-intensity focused ultrasound (HIFU) combined with transcatheter arterial chemoembolization (TACE) in the treatment of hepatocellular carcinoma (HCC).
其他文献
Along with the rise of ultrasonic molecular probe technology, ultrasound molecular imaging has become a hot topic in medical imaging research.
会议
Though China has a long-running family planning policy, it does not warrant the chance to get a healthy child.Fertility for the female starts with 10 million germ cells formed around the 8th embryonic
会议
Objective The diagnosis of liver fibrosis in early stage is important for the treatment and evaluation of hepatic diseases.Liver biopsy is currently considered gold standard for diagnosing and staging
会议
We describe results in unresectable pancreatic tumors treated with USgHIFU hyperthermia ablation plus adjuvant chemotherapy.
Introduction: For many decades open surgery remained the only way available for local control of body tumours.In order to decrease the patients morbidity and mortality several image guided minimally i
会议
Objective: The RO resection rate of pancreatic cancer is merely 20%.And the 5-year survival rate is only 5%.For advanced stage pancreatic cancer, non-surgical treatments such as chemotherapy or radiat
会议
Hepatocellular carcinoma (HCC) is one of the commonest cancers in Asia.However, only a small amount of patients is eligible for surgical intervention upon diagnosis.
会议
OBJECTIVE:The purpose of this report is to establish whether USgHIFU ablation can be considered an effective and enhancing auxiliary therapy when treating patients with malignant soft tissue tumors of
会议
Introduction: Malignant liver tumors have a very poor prognosis.Primary hepatocelular carcinoma (HCC) is usually fatal with less than 5% of patients surviving 5 years after diagnosis.
会议
Purpose: High intensity focused ultrasound (HIFU) has been reported to be beneficial to patients with late stage HCC when combining with TACE, by which the one-year survival reached 42.9%.
会议